← Browse by Condition
Medical Condition
metastatic non small cell lung cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3, Phase 1
NCT04410796 Phase 2
Recruiting
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Enrollment
571 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06216301 Phase 3
Recruiting
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Enrollment
734 pts
Location
United States, Austr...
Sponsor
NovoCure GmbH
NCT06066138 Phase 1
Recruiting
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI...